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Abstract 
Background. Physical rehabilitation programs can lead to improvements in mobility in people 
with multiple sclerosis (PwMS). Objective: Identify which rehabilitation program elements 
are employed in real life and how they might impact mobility improvement in PwMS. 
Methods. Participants were divided into improved and non-improved mobility groups based 
on changes observed in the Multiple Sclerosis Walking Scale-12 following multimodal 
physical rehabilitation programs. Analyses were performed at group and subgroup (mild and 
moderate-severe disability) levels. Rehabilitation program elements included: setting; number 
of weeks; number of sessions; total duration, therapy format (individual, group, autonomous), 
therapy goals and therapeutic approaches. Results. The study comprised 279 PwMS from 17 
European centers. PwMS in the improved group received more sessions of individual therapy 
in both subgroups. In the mildly disabled group, 60.9% of the improved received resistance 
training, whereas, 68.5% of the non-improved, received self-stretching. In the moderately-
severely disabled group, 31.4% of the improved, received aerobic training, while 50.4% of the 
non-improved, received passive mobilization/stretching. Conclusions. We believe that our 
findings are an important step in opening the black-box of physical rehabilitation, imparting 
guidance and assisting future research in defining characteristics of effective physical 
rehabilitation. 
Keywords  
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Introduction 
Although numerous trials have established the benefits of immunomodulatory drugs in 
decelerating the inflammatory-related progression of multiple sclerosis (MS),1 the disease 
remains incurable with ambulation difficulties worsening with disease progression. 
Consequently, physical rehabilitation remains a key factor in improving (or maintaining) 
mobility in people with MS (PwMS).  
     Rehabilitation programs comprise various therapeutic approaches (e.g. resistance training, 
balance training, etc.), intensity (e.g. how hard the body is taxed), volume (e.g. frequency, 
number and duration of sessions) and format (e.g. individual or group based; home or center-
based). It has been reported that the content and approach of physical therapy for PwMS 
differs throughout certain European countries .2 Nevertheless, very few studies have hitherto 
investigated which elements are currently being employed during rehabilitation sessions and 
which are of sufficient importance in improving mobility in PwMS. In terms of therapeutic 
approaches, several systematic reviews have examined the effect of physical rehabilitation 
programs on ambulatory outcomes in PwMS.3-7 Although there is strong evidence showing 
that exercise therapy improves mobility related activities,3,4 others have demonstrated only a 
limited beneficial impact.5,8   
     Recently, Khan & Amatya published a systematic review of systematic reviews examining 
rehabilitation in PwMS9 reporting strong evidence for physical rehabilitation programs and 
moderate evidence for a range of rehabilitative treatments and approaches available for 
PwMS. Nevertheless, there is still a lack of evidence for most modalities and limited 
comparative knowledge of their efficacy across the disability spectrum due to the use of 
different outcome measures and limited standardized reporting of the elements in 
rehabilitation programs (e.g. combination of modalities and delivery modus). As such, it is 
difficult to provide sufficiently detailed guidelines to clinicians and patients. Additional 
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information is needed in order to identify core elements in physical rehabilitation programs, 
aimed at improving mobility in PwMS.  
     In our previous publication of 290 PwMS from 17 European centers, we examined the 
responsiveness and clinically meaningful improvement of five walking measures.10 The 
participating centers collaborated with the European Rehabilitation within the Multiple 
Sclerosis (RIMS) network. Our main finding was that long walking tests and the self-reported 
MS walking scale-12 (MSWS-12) could detect clinically meaningful improvement after 
physical rehabilitation.10 The aim of the present study, (a secondary analysis), was to assess 
real-life physical rehabilitation programs across Europe and explore the elements (format, 
volume, therapy goals and approaches) which could positively affect mobility in PwMS. Our 
hypothesis was that active treatment approaches (e.g. muscle strengthening, aerobic training) 
would greatly impact mobility compared to passive approaches (e.g. stretching). 
Methods 
Participants  
A convenience sample of 290 PwMS were recruited from 17 centers within the RIMS 
network. A full description of participating centers was presented in our previous 
publication.10 This study was approved by the Ethical Committee of the Hasselt University, 
Belgium and local ethics committees from each participating center. Inclusion criteria 
comprised a definite diagnosis of MS11 and the Expanded Disability Status Scale (EDSS)12 
score of ≥ 2 and ≤6.5 as determined by neurologists. All patients participated in a physical 
rehabilitation program for 3 to 12 weeks. Inclusion criteria included a minimum of 10 
sessions and a maximum duration of 3 months. Subjects were excluded if afflicted with other 
medical conditions interfering with walking. All subjects provided written informed consent. 
Rehabilitation Program Format and Volume 
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The physical rehabilitation programs varied from center to center and included guided or 
supervised sessions by physiotherapists and/or sport/fitness instructors. We acknowledge that 
there are differences in the educational level of professionals providing physical therapy in 
MS across Europe.13 Each participating site supplied information regarding their program, ie, 
setting; number of weeks; number of sessions; total duration and therapy format (individual, 
group or autonomous). Settings were neuro-rehabilitation centers with or without an overnight 
stay, hospitals with or without an overnight stay, private physical therapy practices, 
community centers, fitness centers, research facilities and patient residences. These were 
dichotomized as in- and outpatient rehabilitation settings. A maximum of two settings were 
indicated when settings were combined. Individual therapy was defined as a 1:1 ratio between 
therapist and patient. The duration of each session lasted 40-50 minutes. Number of sessions 
and total duration were recorded for each therapy format.  
Therapy Goals and Therapeutic Approaches 
Classification of therapy goals and therapeutic approaches were based on Rasova et al’s 
study.14,15 Therapists were required to describe for each patient one primary goal of the 
physical rehabilitation program: "improving balance", "improving walking capacity", 
"maintenance of balance and walking" and "others, unrelated to balance and walking". In 
order to identify the main therapeutic approaches employed during the intervention program, 
the therapist selected a maximum of 5 items (out of 21) from a list of approaches (e.g 
resistance training with equipment, balance training, gait training, passive mobilisation, 
aerobic training, etc).  
Walking Measures 
Clinical walking tests used at entry and discharge of the rehabilitation program included: 
1) Two- and six-minute walk test (2mWT, 6mWT). The participants were instructed to 
complete the test ‘at their fastest speed’ and cover as much distance as possible by 
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walking up and down a 30 meter hallway, using their own walking aid. The 2mWT 
and 6mWT have been validated and used extensively in PwMS.16  
2)  The MSWS-12 is a valid patient-reported questionnaire rating walking ability in 
PwMS.17,18 Each item is scored on a 1 to 5 scale; the higher the score, the more perceived 
walking difficulties. A total score is generated and converted to a 0 to 100 scale with negative 
change scores indicating improvement.  
3) Timed 25-Foot Walk (T25FW) was performed at a normal and fastest walking speed. 
Participants were instructed to walk at their own comfortable pace for the normal trial and as 
quickly as possible for the fast trial. The T25FW has been validated as one of the three 
components of the Multiple Sclerosis Functional Composite.19  
Statistical Analysis 
The sample group was divided into two groups: improved and non-improved walkers. 
Allocation was determined according to the MSWS-12’s minimally important change (MIC) 
scores as presented in our previous publication.10 The MSWS-12 was selected due to its 
acceptance in clinical trials investigating rehabilitation and pharmacological interventions in 
the MS population. Additionally, its validity has been confirmed in community-residing and 
hospital outpatient samples of PwMS17,18.  
     The MIC cut-off point for the total group was -11.35; in the mildly disabled subgroup -
10.7 and in the moderately-severely disabled -11.85. PwMS with change scores equal or 
above the MIC were assigned to the improved group and those scoring below the MIC were 
assigned to the non-improved group. Furthermore, the participants were categorized as either 
“mildly” (EDSS ≤4) or “moderately-severely” disabled (EDSS >4), according to their 
disability level. Classification of disability subgroups corresponded with our previous 
publications on walking measures in PwMS.10,20 All data followed a normal distribution 
according to the Kolmogorov-Smirnov test. Box plots determined outliers for each outcome.  
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      Descriptive statistics were used for demographic, clinical characteristics, rehabilitation 
elements and mobility measures. Differences between the improved and non-improved 
walkers were examined by the chi-square test for MS type, gender, setting, therapy goals and 
by analysis of variance tests (ANOVA) for age, disease duration, EDSS, mobility measures, 
volume of therapy and therapeutic approaches.  
    Binary logistic regression analyses, with a forward method, examined the relationship 
between the improved/non-improved status (dependent variable) and the rehabilitation 
elements (setting, therapy goal, volume of therapy and therapeutic approaches) (independent 
variables). The regression analysis was performed separately according to disability 
subgroups. For all models, the assumptions underlying regression were tested by inspecting 
the distribution of the error term. All analyses were carried out using the SPSS software 
(version 25.0 for Windows; SPSS Inc., Chicago, Illinois, USA). Reported P values were two-
tailed. The level of significance was set at p<0.05. 
Results 
Out of the total 290 PwMS, 11 participants were missing data, therefore, only a total of 279 
PwMS were included in the final analysis: 131 were assigned to the improved; 148 to the non-
improved group. No significant differences between groups were observed for age, gender 
distribution, type of MS, disease duration and mean EDSS score. Descriptive characteristics 
of the sample according to group allocation and disability level are provided in Table 1.  
Place Table 1 here 
 In terms of disability subgroups, 46 patients (47.9%) in the mildly disabled and 70 (38.3%) 
in the moderately-severely disabled, improved in mobility. No differences were detected 
between the improved and non-improved subgroups as to demographic and clinical 
characteristics on the moderately-severely disability level. A similar observation was recorded 
in the mildly disabled group, with the exception of the mean EDSS score which was higher in 
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those who improved compared to those who did not, 3.3 (S.D.=0.8) vs. 2.8 (S.D.=1.0), 
p=0.013. Descriptive and clinical characteristics according to group allocation and disability 
level are provided in Table 1.  
      Table 2 and figure 1 present the mobility outcome measures according to group allocation 
and disability level. For the total sample, significant differences were found in favor of the 
improved compared to the non-improved group for the 2mWT and the 6mWT. No differences 
between groups were found for the T25FW. According to the 2-and 6mWT, PwMS improved 
their walking distance by approximately twice the length of the non-improved PwMS. 
Although, individuals in the non-improved group showed improvements in the long distance 
walking tests, it was below the MIC cutoff score.  
Place Table 2 and Figure 1 here 
      No differences were found between the improved and non-improved groups in the 
T25FW, 2 and 6MWT mobility tests for people with mild MS. In contrast, significant 
differences in favor of the improved group were found for the long distance walking tests in 
moderately-severe PwMS. As for the MSWS-12 questionnaire, participants in the improved 
group (both disability levels) presented with a ~26% improvement at discharge. Conversely, 
people with mild or moderately-severe MS, categorized as non-improved, reported more 
mobility difficulties (according to the MSWS-12) following the physical rehabilitation 
program.  
      The majority (72%) of the MS sample received rehabilitation in an outpatient setting. No 
significant differences in the amount of therapy was found between the mildly and 
moderately-severely disabled subgroups. PwMS in the improved group received a greater 
amount of individual therapy compared to the non-improved in both disability subgroups. 
People with mild MS who had improved, received approximately twice the number of 
individual therapy sessions and double the duration of therapy hours compared to those who 
Improving mobility in MS across Europe  
 
had not improved. Participants in the improved group, classified as moderately-severely 
disabled, received approximately 25% more individual therapy compared to those in the non-
improved group. No differences were observed between the improved and non-improved 
groups in program settings and amount of autonomous therapy, regardless of disability level. 
Table 3 presents the rehabilitation program elements according to group allocation and 
disability level. 
Place Table 3 here 
       Approximately 42% of the therapists, selected "improvement in walking capacity" as the 
primary goal for participants who had improved, irrespective of disability level. According to 
the chi-square tests, there were significant differences in therapy goals between the improved 
and non-improved groups in the mildly disabled subgroup; χ2(3)=18.537, p<0.001 and in the 
moderately-severely disabled subgroup; χ2(3)=16.538, p=0.001. Figure 2 illustrates therapy 
goal distribution according to group allocation and disability level.  
Place Figure 2 here 
     The therapist was instructed to select a maximum of 5 items (out of 21) from a list of 
therapeutic approaches. Significant differences were found in the mildly disabled group for 
two items; 60.9% of the participants who had improved, had received resistance training 
compared with 26.0% who had not improved; whereas, 68.5% of those who had not 
improved, had received self-stretching compared to 39.1% who had improved. As for the 
moderately-severely disabled group, 31.4% who had improved had received aerobic training 
compared to 14.2% who had not improved). In patients who had not improved, 50.4% 
received passive mobilization/stretching compared to 31.4% who had improved), 38.9% 
received resistance training compared to 21.4% who had improved. Table 4 presents the 
therapy approaches according to group allocation and disability level. 
Place Table 4 here 
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     Table 5 presents the results of the binary regression analysis in the mildly and moderately-
severely disabled subgroups. A significant relationship was found between group allocation 
with resistance training and self-stretching therapeutic approaches in the mildly disabled 
subgroup. These variables explained 21.8% of the variance related to improved/non-improved 
group allocation. As for the moderately-severely disabled subgroup, passive mobilization/ 
stretching and individual therapy volume explained 14.3% of the variance related to 
improved/non-improved status.  
Place Table 5 here 
Discussion 
We report herein on a secondary analyses of a RIMS multicenter study primarily aimed at 
investigating the responsiveness of outcome measures in rehabilitation. Our aim was to assess 
physical active rehabilitation programs and explore the elements of these programs which 
positively affect mobility in PwMS. Upon conclusion of the rehabilitation program, 47% of 
PwMS participants demonstrated a clinical meaningful improvement in the MSWS-12. A 
novel feature of the current study was that while most of the previous studies investigating 
physical rehabilitation in PwMS had observed improvements in mobility according to the 
standard significance level, we defined mobility improvements according to meaningful 
clinical values.10  
     To the best of our knowledge, this is the first multicenter study encompassing a wide range 
of physical rehabilitation programs applied in the MS population, using identical outcome 
measures and standardized reporting terminology. We combined the data obtained from 17 
MS rehabilitation centers in 9 countries. Each center had constructed their program according 
to the needs of their local MS population, rehabilitation facilities and the regulations/ 
guidelines of its health care providers. Mobility assessments were performed in a standardized 
manner at all centers according to a detailed instruction booklet provided by the project 
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steering group. Although the diverse rehabilitation programs and the possibility that therapists   
employed multiple approaches per patient may affect the data and can be considered a 
limitation, we feel that it might strengthen the ecological validity of our findings. 
Furthermore, in the current study we did not want to change the existing physical 
rehabilitation programs. The format was to observe and record the current status of physical 
rehabilitation across Europe in PwMS14,15, without formulating up a well-designed 
(controlling co-founders), scientifically strong robust study. We believe that our findings are 
an important step in opening the black-box of physical rehabilitation, imparting guidance and 
assisting future research in defining characteristics of effective physical rehabilitation.  
     There is a wide-ranging consensus as to the amount of physical rehabilitation needed for 
PwMS: more practice is probably better, but “how much more” remains an unanswered 
question. We found that the volume of individual therapy was significantly higher in 
improved versus non-improved patients, consistent in both disability groups, suggesting that 
the volume of rehabilitation is a key factor for a successful rehabilitation in PwMS. This 
statement is in accordance with a Cochrane review examining physical rehabilitation 
approaches in patients recovering function and mobility following stroke.21 Nevertheless, our 
findings partially contrast with Snook & Motl’s systematic review who reported on the effect 
of exercise on mobility performance in PwMS. They found no differences in effect size 
according to the number of sessions per week and minutes per session.4 Unfortunately, the 
authors did not calculate the total amount of exercise therapy and consequently, a direct 
comparison with our findings is not possible. 
      Findings related to the therapy goals were somewhat confusing. The goal "Other" was the 
main choice in the mildly disabled participants who did not improve, however, this was also 
the main goal of choice in the moderate-severe disabled participants. According to the study 
protocol, the therapists were asked to record only the primary goal, although the training 
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sessions may have included additional secondary goals (reflecting real life practice), such as 
improving walking capacity and/or balance. For instance, in cases where improving aerobic 
capacity was the main goal, the therapist chose the option "Other". However, this choice does 
not necessarily mean that secondary objectives such as improving walking and/or balance, 
were not included in the session. We therefore, advise to consider this finding with caution. 
     Currently, there is no consensus as to whether group or individual therapy (or a 
combination of both) sessions are preferred when seeking to improve mobility functions in 
PwMS.22,23 Although, group-based physical rehabilitation sessions may be more efficient by 
potentially allowing more visits per patient than individual physical therapy sessions, there 
are still several potential disadvantages to this approach. One disadvantage is the lack of 
flexibility in tailoring interventions according to the varied functional levels of individual MS 
patients. Moreover, it is more difficult to match the patient's cognitive and psychological 
function in group therapy compared with individual therapy treatment goals. On the other 
hand, advantages of group therapy include social interaction and peer support between 
participants. Our findings suggest that individual therapy should be preferred over group or 
autonomous therapy in order to improve mobility in the MS population. Nevertheless, future 
research is warranted with a direct comparison of an identical rehabilitation program provided 
in individual vs. group therapy settings. 
     In the mildly disabled group, a significant higher proportion of patients received resistance 
training in the improved group versus the non-improved. The opposite result was seen in the 
moderately-severely disabled group (Table 4). A positive contribution of resistance training 
on mobility has been well-documented in the MS population.24-26 The mechanisms involved 
may include increases in the neural drive,27 a larger muscle fiber size28 and enhanced 
neuromuscular adaptations.29 For patients with a moderate-severe disability, aerobic training, 
rather than resistance training, was associated with clinical meaningful mobility 
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improvements. This finding supports the results of previous studies investigating the effect of 
aerobic exercise in PwMS with severe mobility deficits.30,31 
 Self-stretching and passive mobilization/stretching were more commonly used as a 
treatment approach in PwMS who did not improve. Passive movements, joint mobilization 
and stretching techniques generally produced only modest beneficial effects or even 
detrimental effects on performance in athletes32 Our results also indicate that these therapy 
modalities appear to be less beneficial compared to more physically demanding modalities  
aiming to improve mobility in PwMS. The fact that stretching did not emerge as most 
effective, may be related to the patient sample composition, with limited patients 
demonstrating a need for stretching.  
     Group classification was based on the MSWS-12, the most widely used patient-reported 
measure of perceived limitation in walking due to MS. This decision was reached due to 
evidence from multiple studies supporting its robust measurement performance10,17-18,20,33-35. 
Furthermore, the MSWS-12 includes running, stair climbing, balance, concentration and 
effort needed to walk, therefore, measuring broader aspects of mobility. Moreover, Pilutti et 
al. have shown that the MSWS-12 scores correlate with the T25FW, 6mWT and gait 
kinematics in PwMS.32 Some argue that this scale might not be an ideal choice for measuring 
walking impairment in mildly disabled PwMS or those who walk without a device.34 
Nevertheless, Langeskov-Christensen et al recently reported that the MSWS-12 captures 
impairments more gradually than the 2MWT and 6MWT in people with mild MS, thus, 
suggesting that the MSWS-12 is acceptable when assessing walking in PwMS with a low 
disability status.35 
     Our study has some limitations. Firstly, mobility was evaluated only by clinical walking 
tests and a patient-reported questionnaire. Utilizing instrumented gait devices that provide 
definite gait characteristics, might have expanded our knowledge. However, only a few of the 
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centers participating in this study possessed these tools.36 Secondly, we did not explore the 
impact of different combinations of treatment modalities on an individual level. An 
alternative could have been to apply a standardized recording form of rehabilitation taxonomy 
which requires time recordings of different components per session.37 More detailed data 
would have strengthened our findings, however, recording such detailed information after 
each session was not feasible for the majority of involved therapists. Finally, the aim was not 
to improve mobility in all patients. As such, applied intervention modalities may have also 
suited other therapy goals.  
Conclusion      
This report presents data of the core elements of physical rehabilitation programs associated 
with improving mobility in PwMS from 17 MS centers across Europe. Suggested elements to 
improve mobility include the volume of individual therapy sessions, resistance and aerobic 
therapeutic approaches and placing less emphasis on passive therapeutic techniques. Future 
studies should investigate these treatments. 
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Figures 
Figure 1. Mobility outcome measures according to group allocation of the total group (a), the 
mildly disabled group (b) and the moderately-severely disabled group (c). 
Figure 2. Therapy goal distribution according to group allocation in the mildly disabled group 
(a) and the moderately-severely disabled group (b). 
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Table 1. Descriptive Characteristics According to Study Groups and Disability Level. 
Variable 
Mean (SD), Frequencies, Proportions 
P-Value 
Improved   Non-improved 
Total group    
Number, (%)  131 (47.0%) 148 (53.0%) --- 
Age (y) 49.4 (11.6) 49.9 (10.2) 0.719 
Gender (F/M) 86/45 95/53 0.800 
Type of MS (RR/PP/SP) 77/34/20 70/55/23 0.169 
Disease duration (y) 11.5 (8.3) 12.1 (8.1) 0.546 
EDSS (median/range) 5.0 (4.0-6.0) 5.0 (4.0-6.0) 0.215 
Mild disability group (EDSS=2.0-4.0) 
Number, (%)   46 (47.9%) 50 (52.1%) --- 
Age (y) 47.3 (9.6) 44.8 (10.1) 0.213 
Gender (F/M) 27/19 29/21 0.946 
Type of MS (RR/PP/SP) 31/9/6 36/10/4 0.153 
Disease duration (y) 9.5 (7.5) 7.5 (6.2) 0.524 
EDSS (median/range) 3.5 (2.0-4.0) 3.0 (2.5-4.0) 0.013* 
Moderate-severe disability group (EDSS=4.5-6.5) 
number  70 (38.3%) 113 (61.7%) --- 
Age (y) 51.0 (12.2) 51.9 (9.9) 0.583 
Gender (F/M) 48/22 77/36 0.952 
Type of MS (RR/PP/SP) 38/20/12 42/50/21 0.410 
Disease duration (y) 13.0 (8.3) 14.0 (8.2) 0.101 
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EDSS (median/range) 6.0 (5.0-6.0) 6.0 (5.0-6.5) 0.243 
RR, Relapsing-remitting; PP, Primary progressive; SP, Secondary progressive; EDSS, Expanded disability status scale. 
Improving mobility in MS across Europe  
 
Table 2. Mobility Outcome Measures According to Study Groups and Disability Level. 
Mobility parameter 
Delta Post-Pre (Mean, SD) P-value 
Improved   Non-improved  
Total group    
T25FW (usual) (s) -1.13 (1.90) -0.96 (2.05) 0.512 
T25FW (fastest) (s) -0.91 (1.42) -0.53 (2.03) 0.081 
2MWT (m) 11.90 (16.13) 5.75 (13.61) 0.001* 
6MWT (m) 36.25 (40.87) 16.53 (40.77) <0.001* 
MSWS-12 (score, 0-100) -24.65 (14.86) 4.95 (12.36) <0.001* 
Mild disability group (EDSS=2.0-4.0) 
T25FW (usual) (s) -0.65 (1.71) -0.44 (0.83) 0.504 
T25FW (fastest) (s) -0.63 (1.61) -0.30 (0.65) 0.186 
2MWT (m) 13.08 (14.36) 7.65 (13.14) 0.059 
6MWT (m) 36.16 (43.39) 28.98 (33.66) 0.368 
MSWS-12 (score, 0-100) -27.94 (16.02) 2.21 (11.83) <0.001* 
Moderate-severe disability group (EDSS=4.5-6.5) 
T25FW (usual) (s) -1.31 (2.03) -1.22 (2.23) 0.808 
T25FW (fastest) (s) -1.09 (1.40) -0.69 (2.30) 0.205 
2MWT (m) 11.88 (18.11) 5.24 (13.46) 0.006* 
6MWT (m) 34.19 (41.64) 14.87 (42.83) 0.004* 
MSWS-12 (score, 0-100) -25.54 (14.01) 4.13 (12.92) <0.001* 
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Table 3. Rehabilitation Program Format and Volume According to Study Groups and Disability 
Level.  
Variable  
Mean (S.D) P-value 
Improved  Non-improved   
Mild disability group (EDSS=2.0-4.0) 
Settings 
Inpatient  8 9 
0.939 
Outpatient 38 41 
Amount of therapy  
            Number of weeks 7.3 (4.0) 8.7 (3.8) 0.073 
            Number of sessions 35.3 (34.1) 31.3 (30.7) 0.521 
 Total duration (h) 22.3 (15.4) 22.7 (14.2) 0.896 
Format of therapy 
Individual therapy 
  Number of sessions 15.0 (15.8) 7.9 (13.9) 0.021* 
            Total duration (h) 10.0 (8.7) 5.0 (8.0) 0.004* 
Group therapy 
  Number of sessions 13.7 (20.7) 17.8 (15.7) 0.275 
            Total duration (h) 9.8 (12.7) 15.4 (12.8) 0.033* 
Autonomous therapy 
 Number of sessions 6.9 (17.7) 5.6 (15.8) 0.715 
           Total duration (h) 2.5 (5.2) 2.2 (6.4) 0.828 
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Moderate-severe disability group (EDSS=4.5-6.5) 
Settings    
Inpatient  25 36 
0.593 
Outpatient 45 77 
Amount of therapy     
            Number of weeks 6.0 (3.6) 7.1 (3.6) 0.046* 
            Number of sessions 33.0 (22.2) 30.2 (24.0) 0.424 
 Total duration (h) 23.0 (15.4) 18.6 (12.6) 0.037* 
Format of therapy    
Individual therapy    
  Number of sessions 12.3 (7.8) 10.1 (6.8) 0.050* 
            Total duration (h) 10.0 (7.9) 7.5 (4.9) 0.009* 
Group therapy    
  Number of sessions 10.5 (11.8) 8.2 (11.4) 0.190 
            Total duration (h) 8.6 (10.6) 6.6 (8.5) 0.165 
Autonomous therapy    
 Number of sessions 10.2 (19.9) 11.9 (21.0) 0.606 
           Total duration (h) 4.5 (8.4) 4.5 (9.3) 0.954 
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Table 4. Intervention Approaches According to Study Groups and Disability Level. 
Variable 
% (n) P-value 
Improved  Non-improved   
Mild disability group (EDSS=2.0-4.0) n=46 n=50  
     Balance training  60.9% (28) 44.0% (22)  0.100 
     Gait training - functional approach  30.4% (14) 18.0% (9) 0.157 
     Aerobic training  41.3% (19) 42.0% (21) 0.946 
     Muscle strengthening -without equipment 45.7% (21) 30.0% (15) 0.116 
     Resistance training – with equipment 60.9% (28) 26.0% (13) 0.006* 
     Self-stretching  39.1% (18) 68.5% (34) 0.004* 
     Passive mobilization/stretching  8.7% (4) 12.7% (6) 0.601 
Moderately-severe disability group (EDSS=4.5-6.5) n=70 n=113  
     Balance training  77.1% (54) 69.9% (79) 0.310 
     Gait training - functional approach  60.0% (42) 62.8% (71) 0.755 
     Aerobic training  31.4% (22) 14.2% (16) 0.008* 
     Muscle strengthening -without equipment 41.4% (29) 43.4% (49) 0.878 
     Resistance training – with equipment 21.4% (15) 38.9% (44) 0.010* 
     Self-stretching  31.4% (22) 29.2% (33) 0.744 
     Passive mobilization/stretching  31.4% (22) 50.4% (57) 0.014* 
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Table 5. Binary Logistic Regression Analysis in the Mild and Moderate Disability 
Subgroups. 
 
 
 
  Β (95% CI)   R2  P-Value 
Mild disability group (EDSS=2.0-4.0) 
Step 1 Resistance training -1.461 (0.098, 0.549) 0.154 0.001 
Step 2 Resistance training -1.286 (0.113, 0.674) 
0.218 
0.005 
Self-stretching -1.046 (0.144, 0.860) 0.022 
Moderate-severe disability group (EDSS=4.5-6.5) 
Step 1 Passive mobilization/stretching -0.945 (0.210, 0.719) 0.067 0.003 
Step 2 Passive mobilization/stretching -1.157 (0.163, 0.605) 
0.143 
0.001 
 Individual therapy volume 0.083 (1.033, 1.144) 0.001 
